Literature DB >> 3279579

Late mortality and morbidity five to eighteen years after kidney transplantation.

C Toussaint1, P Kinnaert, P Vereerstraeten.   

Abstract

The experience with 102 kidney transplants (86 from cadaver donors) functioning more than 5 years in 99 patients followed in one center is reviewed. With the 100% survival point set at 5 years, patient and graft survivals were 92% and 73% at 10 years, and 70% and 56% at 15 years, respectively. Of those 102 recipients, 58 are presently alive with a functioning graft and 18 died with a functioning graft; 26 patients rejected their graft after a mean interval of 8.3 years posttransplant, 11 of them died within 4-45 months following readmission to dialysis. For the whole group, 29 patients died after a mean period of 10 years following transplantation. Main causes of death were vascular catastrophes (48%), malignancies (21%), sepsis (17%), and liver failure (14%). Because vascular accidents, hepatic failure, and sepsis predominated in male patients, the overall late mortality was higher in male (37%) than in female (25%) patients. The high incidence of late complications--including chronic and acute graft rejections--in long-term kidney recipients constitutes a strong argument for maintaining constant supervision of those patients by a medical team with extensive experience with transplantation.

Entities:  

Mesh:

Year:  1988        PMID: 3279579     DOI: 10.1097/00007890-198803000-00010

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

Review 1.  Current status of renal transplantation.

Authors:  M G Suranyi; B M Hall
Journal:  West J Med       Date:  1990-06

2.  Transplant-associated autoimmune mechanisms in human hepatitis C virus infection.

Authors:  K Zucker; D Roth; R Cirocco; J Mathew; M Carreno; L Fuller; T Karatzas; Y Jin; G Burke; J Nery; M Webb; A Tzakis; V Esquenazi; J Miller
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

3.  Kidney transplantation in hepatitis B surface antigen carriers.

Authors:  V Kliem; B Ringe; K Holhorst; U Frei
Journal:  Clin Investig       Date:  1994-12

4.  Characteristics of cadaveric renal allograft recipients developing chronic rejection.

Authors:  M C Foster; P A Rowe; M J Dennis; A G Morgan; R P Burden; R W Blamey
Journal:  Ann R Coll Surg Engl       Date:  1990-01       Impact factor: 1.891

5.  Effects of Telmisartan and Candesartan on the Metabolism of Lipids and Glucose in Kidney Transplant Patients: A Prospective, Randomized Crossover Study.

Authors:  Yoshifumi Miura; Hiroshi Noguchi; Yasuhiro Okabe; Kosuke Masutani; Shoji Tokunaga; Masafumi Nakamura
Journal:  Transplant Direct       Date:  2019-01-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.